Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1049 - 1056 of 11616 results
Montana Youth Climate Ruling Leaves Much Ground To Cover
August 18, 2023| News
How Do You Protect Intellectual Property in a Business Transaction?
August 18, 2023| News
Artificial Intelligence and Copyright — AI: The Washington Report
August 17, 2023| Article| Viewpoint
FTC, DOJ Guidelines Could Hinder Health Care Industry Mergers, Antitrust Lawyers Say
August 17, 2023| News
Women-Led Firms Are A Bright Spot In 2023’s Fundraising Slump
August 16, 2023| News
SEC Increases Scrutiny Of Fund Administrators, Financial Attorneys Say Amid Settlements
August 15, 2023| News
‘Forgotten’ 401k Accounts Study Criticized By Fiduciary Professionals
August 15, 2023| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.